Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
biotech
boston blog main
boston top stories
cancer
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
venture capital
abbvie
adverse events database
amunix pharmaceuticals
anifrolumab
antitrust
apremilast
astrazeneca
autoimmune disease
azitra
belantamab mafodotin
biosimilar
boulder/denver blog main
boulder/denver top stories
cancer drugs
celgene
cholesterol
clinical study
clinical trials
cobimetinib
crisis
deal
deals
death
detroit blog main
detroit top stories
died
duchenne muscular dystrophy
evercore isi
fibrogen
What
hit
2
×
abbvie’s
barbecuing
bio
camping
cancer
cardiologist
center
check
cholesterol
conference
day
despite
drug
family
flop
hardest
hottest
hunters
ipo
j
j’s
labor
medicines
monday
opioid
paris
proteins
ras
reels
research
revolution
roundup
sleeping
targets
Language
unset
2
×
Current search:
unset
×
amgen
×
hit
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More